A Randomized, Multi-Center, Phase III Trial of Calcineurin Inhibitor-Free Interventions for Prevention of Graft-versus Host-Disease
Study of Combination Treatment to Reduce Occurrence and Severity of Chronic Graft Versus Host Disease (GVHD)
Sponsor: Blood & Marrow Transplant Clinical Trials Network
Enrolling: Male and Female Patients
IRB Number: AAAO7363
U.S. Govt. ID: NCT02345850
Contact: Jean Sosna, RN: 646-317-2141 / js4403@cumc.columbia.edu
Additional Study Information: The purpose of this study is to compare two different combinations of treatment plans to a standard transplant procedure in order to see whether one or both of them are better at reducing the occurrence and severity of chronic GVHD. The research portion of this study involves manipulation of your stem cell product by removing T-cells, which cause chronic GVHD.
This study is closed
Investigator
Monica Bhatia, MD
Do You Qualify?
Are you between 1 and 66 years old? Yes No
Are you diagnosed with acute leukemia or myelodysplasia? Yes No
Are you in remission? Yes No
Has your treating physician recommended hematopoietic stem cell transplant? Yes No
Submit
Cancel
You may be eligible for this study

Place Holder



Cancel
For more information, please contact:
Jean Sosna, RN
js4403@cumc.columbia.edu
646-317-2141
This website uses cookies as well as similar tools and technologies to understand visitors’ experiences. By continuing to use this website, you consent to Columbia University’s usage of cookies and similar technologies, in accordance with the Columbia University Website Cookie Notice.
I AGREE